Zacks Research Issues Pessimistic Forecast for EHC Earnings

Encompass Health Co. (NYSE:EHC) – Research analysts at Zacks Research lowered their Q4 2025 EPS estimates for Encompass Health in a report released on Wednesday, January 8th. Zacks Research analyst Z. Masood now expects that the company will earn $1.14 per share for the quarter, down from their prior forecast of $1.15. The consensus estimate for Encompass Health’s current full-year earnings is $4.29 per share. Zacks Research also issued estimates for Encompass Health’s Q2 2026 earnings at $1.40 EPS.

Several other equities research analysts also recently weighed in on EHC. Truist Financial reissued a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp increased their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. UBS Group increased their target price on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Barclays raised their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Finally, Royal Bank of Canada raised their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Trading Down 1.9 %

Shares of EHC opened at $91.08 on Friday. Encompass Health has a twelve month low of $67.94 and a twelve month high of $104.55. The company has a market cap of $9.18 billion, a P/E ratio of 22.00, a P/E/G ratio of 1.30 and a beta of 0.89. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The company’s fifty day simple moving average is $98.23 and its 200-day simple moving average is $93.71.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Encompass Health’s revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.86 earnings per share.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in EHC. TD Private Client Wealth LLC boosted its holdings in shares of Encompass Health by 2,870.0% in the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock valued at $709,000 after buying an additional 7,089 shares in the last quarter. Los Angeles Capital Management LLC boosted its holdings in shares of Encompass Health by 532.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after buying an additional 42,338 shares in the last quarter. Pathstone Holdings LLC boosted its holdings in shares of Encompass Health by 54.5% in the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock valued at $2,032,000 after buying an additional 7,412 shares in the last quarter. Deerfield Management Company L.P. Series C bought a new stake in shares of Encompass Health in the 2nd quarter valued at about $541,000. Finally, Meeder Asset Management Inc. boosted its holdings in shares of Encompass Health by 43.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock valued at $6,417,000 after buying an additional 20,242 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.75%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s payout ratio is 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.